Jessica N. Abraham | Designer. Writer. Publicist.

19+ Years of Expertise in Digital Marketing, Social Branding and Public Relations.

  • Home
  • Contact
  • About
  • Home
  • Contact
  • About

No Widgets found in the Sidebar Alt!

  • Statera Biopharmaceuticals, Groundbreaking Biomedicine Treatment
    Health,  Benzinga,  Biotechnology,  Business,  Finance

    Statera BioPharma: The Ticker Formerly Known as CBLI

    September 7, 2021 /

    Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. On September 1, 2021, Cytocom officially became listed as Statera BioPharma, Inc. (NASDAQ: STAB), as it updated its ticker symbol from CLBI to STAB within the Nasdaq markets.  This change in name comes as a natural progression, as the company shifts gears toward placing a more strategic focus on restoring total immune health — including autoimmune and inflammatory diseases, such as fibromyalgia and multiple sclerosis, blood disorders like anemia and lupus, even cancer and various other infectious diseases.  The company began trading as CLBI, last month,…

    read more
    Jessica N. Abraham Comments Off on Statera BioPharma: The Ticker Formerly Known as CBLI

    You May Also Like

    Statera Pharmaceuticals treatment for Covid-19 Long-Haulers

    Groundbreaking Studies to Be Conducted on the Effectiveness of Short and Long-term COVID-19 Therapies Inhibiting the Progression of SARS-CoV-2

    October 28, 2021
    Marijuana Dispensary Unity Rd, Item 9 Medical Marijuana, CBD, Cannabis, Edibles,

    Unity Rd., 100% Locally-Owned and Operated Dispensary Franchise, Strategically Positions Item 9 Labs Corp. for National Scale

    August 30, 2021
    Green Policy, Generation Hemp, Melissa Pagen, Gary C Evans, Industrial Hemp Processor, Hemp Cleaning, Green Policy, ESG

    Generation Hemp’s Green Policy is Inspired by a Cause, Executives Move From Oil and Gas to Industrial Green

    August 30, 2021
  • Medtech Cardiac Monitoring Device, Wearable, Biotricity, Bioflux, Samsung, Watch4,
    Business,  Benzinga,  Finance,  Health,  IoT,  Medtech,  Technology,  Wearable Devices

    Biotricity Reports Q1 Earnings at 290% for FY2022

    September 2, 2021 /

    Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Biotricity (NASDAQ: BTCY) has been taking the world of medtech by storm, introducing primary care providers across the country to its remote heart monitoring devices. Always connected, these wearable devices have been giving power back to those suffering from chronic cardiac conditions and simultaneous comorbidities — the simultaneous presence of two or more diseases or medical conditions and often relative of one another.  Through remote heart monitoring and diagnostic technologies, doctors can screen their patients from a distance, even alerted to a possible emergency if the…

    read more
    Jessica N. Abraham Comments Off on Biotricity Reports Q1 Earnings at 290% for FY2022

    You May Also Like

    Top Fintechs, Best Fintechs, Columbus Ohio,

    BEST FINTECHS IN COLUMBUS, RANKED

    July 21, 2021
    Battle Approved Motors, Benzinga, Electric Cars, EVs, Electric Vehicles, Racing, UTVs, Climate, Energy, Vehicles, Glamping, Camping, Outdoors, Chris James,

    What is a UTV, and Why Might Investing in BAM be a Good Idea?

    July 22, 2021
    Brand Image, Brand Persona, Rebranding, 50 Shades of Branding, Remote Teams, CMS, Content Management Systems, Database, Shutterstock, The Vault, Tools, WebDem, Examiner, Digital Asset Management, Content Development, Collaboration, Branding, Brand Monitoring,

    WebDAM sets the ground rules and gives you ‘Fifty Shades of Branding’

    February 13, 2015
  • Business
  • Technology
  • Career Development
  • Education
  • Entertainment
  • Fashion
  • Relationships
  • Tips
  • Travel
Ashe Theme by WP Royal.